ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

Pohlmeyer et al.
Papers
PLOS ONE
February 2018
Authors and Affiliates
Christopher W. Pohlmeyer1, Sarah B. Laskey1, Sarah E. Beck2, Daniel C. Xu1, Adam A. Capoferri1, Caroline C. Garliss1, Megan E. May1, Alison Livingston1, Walt Lichmira3, Richard D. Moore1, M. Sue Leffell1, Nicholas J. Butler4, Jennifer E. Thorne4, John A. Flynn1, Robert F. Siliciano1,5, Joel N. Blankson1,2 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, 2Department of Molecular and Comparative Pathobiology. Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, 3Spondylitis Association of America, Philadelphia, Pennsylvania United States of America, 4Department of Ophthalmology. Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, 5Howard Hughes Medical Institute, Baltimore, Maryland, United States of America